Design, synthesis and screening of a drug discovery library based on an Eremophila-derived serrulatane scaffold
File version
Accepted Manuscript (AM)
Author(s)
Lum, Kah Yean
Taki, Aya C
Gasser, Robin B
Byrne, Joseph J
Wang, Tao
Blaskovich, Mark AT
Register, Emery T
Montaner, Luis J
Tietjen, Ian
Davis, Rohan A
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
Abstract
Chemical studies of the aerial parts of the Australian desert plant Eremophila microtheca afforded the targeted and known diterpenoid scaffolds, 3,7,8-trihydroxyserrulat-14-en-19-oic acid and 3-acetoxy-7,8-dihydroxyserrulat-14-en-19-oic acid. The most abundant serrulatane scaffold was converted to the poly-methyl derivatives, 3-hydroxy-7,8-dimethoxyserrulat-14-en-19-oic acid methyl ester and 3,7,8-trimethoxyserrulat-14-en-19-oic acid methyl ester using simple and rapid methylation conditions consisting of DMSO, NaOH and MeI at room temperature. Subsequently a 12-membered amide library was synthesised by reacting the methylated scaffolds with a diverse series of commercial primary amines. The chemical structures of the 12 undescribed semi-synthetic analogues were fully characterised following 1D/2D NMR, MS, UV, ECD and [α]D data analyses. All compounds were evaluated for their anthelmintic, anti-microbial and anti-viral activities. While none of the compounds significantly inhibited motility or development of the exsheathed third-stage larvae (xL3s) of a pathogenic ruminant parasite, Haemonchus contortus, the tri-methylated analogue induced a skinny phenotype in fourth-stage larvae (L4s) after seven days of treatment (IC50 = 14 μM). Anti-bacterial and anti-fungal activities were not observed at concentrations up to 20 μM. Activity against HIV latency reversal was tested in inducible, chronically-infected cells, with the tri-methylated analogue being the most active (EC50 = 38 μM).
Journal Title
Phytochemistry
Conference Title
Book Title
Edition
Volume
190
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2021 Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (http://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, providing that the work is properly cited.
Item Access Status
Note
Access the data
Related item(s)
Subject
Chemical sciences
Biological sciences
Health sciences
Amide
Anthelmintic
Anti-HIV
Anti-bacterial
Anti-fungal
Persistent link to this record
Citation
Zhang, C; Lum, KY; Taki, AC; Gasser, RB; Byrne, JJ; Wang, T; Blaskovich, MAT; Register, ET; Montaner, LJ; Tietjen, I; Davis, RA, Design, synthesis and screening of a drug discovery library based on an Eremophila-derived serrulatane scaffold, Phytochemistry, 2021, 190, pp. 112887